BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Tenax Therapeutics (Formerly Known As Oxygen Biotherapeutics, Inc.) 

3189 Airway Avenue, Building C

Costa Mesa  California  92626  U.S.A.
Phone: 800-809-6054 Fax: 714-427-6361


SEARCH JOBS










 Company News
Oxygen Biotherapeutics, Inc. Announces Name Change To Tenax Therapeutics 9/16/2014 8:54:32 AM
Oxygen Biotherapeutics, Inc. (OXBT) Shares Gyrate After Halting Mid-Stage Brain Injury Trial 9/11/2014 4:05:41 PM
Oxygen Biotherapeutics, Inc. (OXBT) To Present At Wedbush 2014 Life Sciences Management Access Conference 8/8/2014 9:04:59 AM
Oxygen Biotherapeutics, Inc. (OXBT) Announces Collaboration With Imperial College London To Accelerate Enrollment Of Leopards Trial 8/6/2014 10:48:00 AM
Oxygen Biotherapeutics, Inc. (OXBT) Announces Collaboration With Imperial College London To Accelerate Enrollment Of Leopards Trial 8/6/2014 9:25:25 AM
Oxygen Biotherapeutics, Inc. (OXBT) Announces Fiscal Year 2014 Financial Results 7/29/2014 9:42:20 AM
Oxygen Biotherapeutics, Inc. (OXBT) To Announce Fourth Quarter And Fiscal Year 2014 Financial Results On July 29, 2014 7/23/2014 1:33:43 PM
Oxygen Biotherapeutics, Inc. (OXBT) Release: Recent Scientific Publications Highlight Potential Benefits Of Levosimendan In Cardiac Surgery And Additional Critical Care Conditions 7/9/2014 10:54:48 AM
Oxygen Biotherapeutics, Inc. (OXBT) Announces Formation Of Steering Committee For Phase 3 LEVO-CTS Trial Of Levosimendan 6/2/2014 10:55:01 AM
Oxygen Biotherapeutics, Inc. (OXBT) Late-Stage Clinical Trials Could Bode Well For Shareholders Analyst Reports 5/12/2014 8:26:53 AM
12345678910...